Is Natural Health Trends Corp. overvalued or undervalued?
As of February 10, 2021, Natural Health Trends Corp. has improved to a "very attractive" valuation grade, but it appears overvalued with a high P/E ratio of 62 and a 1-year return of -31.32%, significantly underperforming compared to its peers and the S&P 500.
As of 10 February 2021, the valuation grade for Natural Health Trends Corp. has moved from risky to very attractive. Despite this positive shift, the company appears to be overvalued based on its high P/E ratio of 62, a PEG ratio of 30.35, and a price-to-book value of 2.00, which significantly exceeds typical industry benchmarks. In comparison, peers such as Nu Skin Enterprises, Inc. have a P/E of 5.47 and a PEG of 0.005, indicating that Natural Health Trends Corp. is trading at a premium relative to its competitors.Additionally, the company's recent stock performance has been underwhelming, with a 1-year return of -31.32% compared to the S&P 500's gain of 17.14%. This stark contrast reinforces the notion that the stock may not be justified at its current valuation levels. Overall, while the valuation grade suggests improvement, the metrics indicate that Natural Health Trends Corp. is overvalued in the current market context.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
